These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 37806498)

  • 1. Synthesis and biological activity assay of novel camptothecin-peptidic conjugates based on PEPT1.
    Zhang Q; Zou P; Zhu M; Sui D; Wang S; Hu Z; Wang Y; Jing L; Zheng J
    Bioorg Med Chem Lett; 2023 Nov; 96():129502. PubMed ID: 37806498
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increasing oral absorption of polar neuraminidase inhibitors: a prodrug transporter approach applied to oseltamivir analogue.
    Gupta D; Varghese Gupta S; Dahan A; Tsume Y; Hilfinger J; Lee KD; Amidon GL
    Mol Pharm; 2013 Feb; 10(2):512-22. PubMed ID: 23244438
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PSMA-Oriented Target Delivery of Novel Anticancer Prodrugs: Design, Synthesis, and Biological Evaluations of Oligopeptide-Camptothecin Conjugates.
    Xu B; Zhou F; Yan MM; Cai DS; Guo WB; Yang YQ; Jia XH; Zhang WX; Li T; Ma T; Wang PL; Lei HM
    Int J Mol Sci; 2018 Oct; 19(10):. PubMed ID: 30347770
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thiodipeptides targeting the intestinal oligopeptide transporter as a general approach to improving oral drug delivery.
    Foley DW; Pathak RB; Phillips TR; Wilson GL; Bailey PD; Pieri M; Senan A; Meredith D
    Eur J Med Chem; 2018 Aug; 156():180-189. PubMed ID: 30006163
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intestinal absorption and activation of decitabine amino acid ester prodrugs mediated by peptide transporter PEPT1 and enterocyte enzymes.
    Tao W; Zhao D; Sun M; Wang Z; Lin B; Bao Y; Li Y; He Z; Sun Y; Sun J
    Int J Pharm; 2018 Apr; 541(1-2):64-71. PubMed ID: 29471144
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In Vitro and Clinical Evaluations of the Drug-Drug Interaction Potential of a Metabotropic Glutamate 2/3 Receptor Agonist Prodrug with Intestinal Peptide Transporter 1.
    Pak YA; Long AJ; Annes WF; Witcher JW; Knadler MP; Ayan-Oshodi MA; Mitchell MI; Leese P; Hillgren KM
    Drug Metab Dispos; 2017 Feb; 45(2):137-144. PubMed ID: 27895114
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeted delivery to PEPT1-overexpressing cells: acidic, basic, and secondary floxuridine amino acid ester prodrugs.
    Landowski CP; Vig BS; Song X; Amidon GL
    Mol Cancer Ther; 2005 Apr; 4(4):659-67. PubMed ID: 15827340
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bifunctional peptidomimetic prodrugs of didanosine for improved intestinal permeability and enhanced acidic stability: synthesis, transepithelial transport, chemical stability and pharmacokinetics.
    Yan Z; Sun J; Chang Y; Liu Y; Fu Q; Xu Y; Sun Y; Pu X; Zhang Y; Jing Y; Yin S; Zhu M; Wang Y; He Z
    Mol Pharm; 2011 Apr; 8(2):319-29. PubMed ID: 21280612
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activation of a camptothecin prodrug by specific carboxylesterases as predicted by quantitative structure-activity relationship and molecular docking studies.
    Yoon KJ; Krull EJ; Morton CL; Bornmann WG; Lee RE; Potter PM; Danks MK
    Mol Cancer Ther; 2003 Nov; 2(11):1171-81. PubMed ID: 14617791
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and optimization of a bifunctional hyaluronan-based camptothecin prodrug.
    Xu Z; Zheng W; Yin Z
    Arch Pharm (Weinheim); 2014 Apr; 347(4):240-6. PubMed ID: 24402828
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The self-assembling camptothecin-tocopherol prodrug: An effective approach for formulating camptothecin.
    Lu J; Liu C; Wang P; Ghazwani M; Xu J; Huang Y; Ma X; Zhang P; Li S
    Biomaterials; 2015 Sep; 62():176-87. PubMed ID: 26057133
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of albumin-binding camptothecin prodrugs using a Peptide positional scanning library.
    Schmid B; Warnecke A; Fichtner I; Jung M; Kratz F
    Bioconjug Chem; 2007; 18(6):1786-99. PubMed ID: 17915955
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CD147 Monoclonal Antibody Targeted Reduction-Responsive Camptothecin Polyphosphoester Nanomedicine for Drug Delivery in Hepatocellular Carcinoma Cells.
    Tian H; Huang Y; He J; Zhang M; Ni P
    ACS Appl Bio Mater; 2021 May; 4(5):4422-4431. PubMed ID: 35006854
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Propylene glycol-linked amino acid/dipeptide diester prodrugs of oleanolic acid for PepT1-mediated transport: synthesis, intestinal permeability, and pharmacokinetics.
    Cao F; Gao Y; Wang M; Fang L; Ping Q
    Mol Pharm; 2013 Apr; 10(4):1378-87. PubMed ID: 23339520
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prodrug design targeting intestinal PepT1 for improved oral absorption: design and performance.
    Zhang Y; Sun J; Sun Y; Wang Y; He Z
    Curr Drug Metab; 2013 Jul; 14(6):675-87. PubMed ID: 23869811
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ethylene glycol-linked amino acid diester prodrugs of oleanolic acid for PepT1-mediated transport: synthesis, intestinal permeability and pharmacokinetics.
    Cao F; Jia J; Yin Z; Gao Y; Sha L; Lai Y; Ping Q; Zhang Y
    Mol Pharm; 2012 Aug; 9(8):2127-35. PubMed ID: 22352697
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dipeptide-modified nanoparticles to facilitate oral docetaxel delivery: new insights into PepT1-mediated targeting strategy.
    Du Y; Tian C; Wang M; Huang D; Wei W; Liu Y; Li L; Sun B; Kou L; Kan Q; Liu K; Luo C; Sun J; He Z
    Drug Deliv; 2018 Nov; 25(1):1403-1413. PubMed ID: 29890854
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficient Click Synthesis of a Protonized and Reduction-Sensitive Amphiphilic Small-Molecule Prodrug Containing Camptothecin and Gemcitabine for a Drug Self-Delivery System.
    Dong S; He J; Sun Y; Li D; Li L; Zhang M; Ni P
    Mol Pharm; 2019 Sep; 16(9):3770-3779. PubMed ID: 31348660
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bioreduction activated prodrugs of camptothecin: molecular design, synthesis, activation mechanism and hypoxia selective cytotoxicity.
    Zhang Z; Tanabe K; Hatta H; Nishimoto S
    Org Biomol Chem; 2005 May; 3(10):1905-10. PubMed ID: 15889173
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Zwitterionic rhodamine-CPT prodrug nanoparticles with GSH/H
    Mu X; Huang Z; Feng W; Zhai M; Wang Y; Zhou D; Zhou X
    Theranostics; 2023; 13(1):267-277. PubMed ID: 36593965
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.